Stock Scorecard
Stock Summary for Rafael Holdings Inc - Class B (RFL) - $1.71 as of 4/26/2024 3:42:26 PM EST
Total Score
15 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for RFL
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RFL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RFL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for RFL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for RFL
Financial Details for RFL
Company Overview |
|
|---|---|
| Ticker | RFL |
| Company Name | Rafael Holdings Inc - Class B |
| Country | USA |
| Description | Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey. |
| Sector Name | REAL ESTATE & CONSTRUCTION |
| Industry Name | REAL ESTATE |
| Most Recent Quarter | 1/31/2024 |
| Next Earnings Date | 6/11/2024 |
Stock Price History |
|
| Last Day Price | 1.71 |
| Last Day Price Updated | 4/26/2024 3:42:26 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | 19,473 |
| 52-Week High | 2.52 |
| 52-Week Low | 1.44 |
| Last Price to 52 Week Low | 18.75% |
Valuation Measures |
|
| Trailing PE | 17.05 |
| Industry PE | 44.14 |
| Sector PE | 64.69 |
| 5-Year Average PE | -12.69 |
| Free Cash Flow Ratio | 0.57 |
| Industry Free Cash Flow Ratio | 30.63 |
| Sector Free Cash Flow Ratio | 172.38 |
| Current Ratio Most Recent Quarter | 23.01 |
| Total Cash Per Share | 3.01 |
| Book Value Per Share Most Recent Quarter | 4.29 |
| Price to Book Ratio | 0.39 |
| Industry Price to Book Ratio | 1.51 |
| Sector Price to Book Ratio | 3.49 |
| Price to Sales Ratio Twelve Trailing Months | 148.40 |
| Industry Price to Sales Ratio Twelve Trailing Months | 10.87 |
| Sector Price to Sales Ratio Twelve Trailing Months | 3.47 |
Share Statistics |
|
| Total Shares Outstanding | 23,797,300 |
| Market Capitalization | 40,693,383 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 98.50% |
| Reported EPS 12 Trailing Months | 0.10 |
| Reported EPS Past Year | 0.10 |
| Reported EPS Prior Year | -0.08 |
| Net Income Twelve Trailing Months | 2,191,000 |
| Net Income Past Year | -1,876,000 |
| Net Income Prior Year | -124,658,000 |
| Quarterly Revenue Growth YOY | -2.90% |
| 5-Year Revenue Growth | -42.32% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 71,687,000 |
| Total Cash Past Year | 79,506,000 |
| Total Cash Prior Year | 63,235,000 |
| Net Cash Position Most Recent Quarter | 33,087,000 |
| Net Cash Position Past Year | 64,506,000 |
| Long Term Debt Past Year | 15,000,000 |
| Long Term Debt Prior Year | 30,000,000 |
| Total Debt Most Recent Quarter | 38,600,000 |
| Equity to Debt Ratio Past Year | 0.87 |
| Equity to Debt Ratio Most Recent Quarter | 0.73 |
| Total Stockholder Equity Past Year | 100,293,000 |
| Total Stockholder Equity Prior Year | 100,515,000 |
| Total Stockholder Equity Most Recent Quarter | 104,939,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 1.64 |
| 20-Day Bollinger Middle Band | 1.77 |
| 20-Day Bollinger Upper Band | 1.90 |
| Beta | 1.27 |
| RSI | 48.60 |
| 50-Day SMA | 1.93 |
| 200-Day SMA | 12.68 |
System |
|
| Modified | 4/27/2024 10:15:08 AM EST |